Post-earnings recap
Reported
Tue, Oct 27, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Illumina's earnings report showed a positive surprise in EPS, which likely contributed to the 1.56% increase in stock price. The management's focus on innovation and strong demand for their products indicates a positive outlook for the company. However, the lack of revenue data and guidance leaves some uncertainty for investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.24 | N/A | +19.40% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's growth potential. They noted the importance of continued innovation in driving future success.
Management highlighted strong demand for genomic solutions.
They emphasized ongoing investments in innovation despite market challenges.